Bevacizumab Intravenous and Oncaspar

• Generic Name: bevacizumab
• Dosage Forms: n.a.
• Other Brand Names: Avastin, Mvasi

Bevacizumab injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum. Bevacizumab is also used to treat a certain type of metastatic lung cancer called nonsquamous, non-small cell lung cancer, and a certain type of brain tumor called glioblastoma that keeps coming back (recurrent).

Bevacizumab injection is also used in combination with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body. Bevacizumab is also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan, carboplatin and paclitaxel, or carboplatin and gemcitabine followed by Avastin® alone) to treat patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with or without having previous surgery.

Bevacizumab is a substance that helps the body fight cancer. It prevents the growth of certain types of blood vessels to cancer cells. This helps to decrease the growth of cancer cells by starving the cells of nutrients that are needed to grow.

Bevacizumab is to be given only by or under the immediate supervision of your doctor.

• Generic Name: pegaspargase
• Dosage Forms: injection, solution
• Other Brand Names: Oncaspar

Oncaspar is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Oncaspar is used in combination with other cancer medications to treat acute lymphoblastic leukemia. Oncaspar is also used to treat allergic reactions to another cancer medication called asparaginase (Elspar).

Oncaspar may also be used for purposes not listed in this medication guide.